Comparing Antipsychotic Medications in LBD Over Time

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2022
The primary objective of this study is to determine whether treatment with pimavanserin or quetiapine is associated with a greater improvement in psychosis when used in a routine clinical setting to treat hallucinations and/or delusions due to Parkinson\'s disease (PD) or dementia with Lewy bodies (DLB) - collectively referred to as Lewy body disease (LBD).
Epistemonikos ID: d4867c561d806e1814aaf277fb7c5eaeb78b4f9e
First added on: May 14, 2024